Short Interest in CSL Limited (OTCMKTS:CSLLY) Increases By 683.3%

CSL Limited (OTCMKTS:CSLLY) saw a large growth in short interest during the month of December. As of December 15th, there was short interest totalling 4,700 shares, a growth of 683.3% from the November 30th total of 600 shares. Based on an average trading volume of 102,500 shares, the short-interest ratio is currently 0.0 days.

CSL Stock Performance

Shares of CSLLY stock traded down $0.19 during mid-day trading on Thursday, hitting $88.56. 86,311 shares of the company’s stock were exchanged, compared to its average volume of 37,930. The company has a debt-to-equity ratio of 0.58, a current ratio of 2.18 and a quick ratio of 0.97. CSL has a fifty-two week low of $83.31 and a fifty-two week high of $109.00. The stock has a 50-day simple moving average of $92.02 and a two-hundred day simple moving average of $97.54.

About CSL

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.